COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,590 Articles (22,905 medRxiv, 8,685 bioRxiv)

Most recent first Previous |  Page 1867: Articles 18661-18670  | Next

Multi-specific DARPin(R) therapeutics demonstrate very high potency against mutated SARS-CoV-2 variants in vitro
Rothenberger, S., Walser, M., Malvezzi, F., Mayor, J., Ryter, S., Moreno, H., Liechti, N., Halg, S., Bosshart, A., Iss, C., Calabro, V., Cornelius, A., Hospodarsch, T., Neculcea, A., Looser, T., Mangold, S., Reichen, C., Radom, F., Dawson, K. M., Lewis, S., Steiner, D., Amstutz, P., Engler, O., Stumpp, M. T.
10.1101/2021.02.03.429164 — Posted: 2021-02-03
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
Graham, C., Seow, J., Huettner, I., Khan, H., Kouphou, N., Acors, S., Winstone, H., Pickering, S., Pedro Galao, R., Jose Lista, M., Jimenez-Guardeno, J. M., Laing, A. G., Wu, Y., Joseph, M., Muir, L., Ng, W. M., Duyvesteyn, H. M. E., Zhao, Y., Bowden, T. A., Shankar-Hari, M., Rosa, A., Cherepanov, P., McCoy, L. E., Hayday, A. C., Neil, S. J. D., Malim, M. H., Doores, K. J.
10.1101/2021.02.03.429355 — Posted: 2021-02-03
Potential global impact of the N501Y mutation on MHC-II presentation and immune escape
Castro, A., Carter, H., Zanetti, M.
10.1101/2021.02.02.429431 — Posted: 2021-02-03
Full Brain and Lung Prophylaxis against SARS-CoV-2 by Intranasal Lentiviral Vaccination in a New hACE2 Transgenic Mouse Model or Golden Hamsters
Ku, M.-W., Authie, P., Bourgine, M., Anna, F., Noirat, A., Moncoq, F., Vesin, B., Nevo, F., Lopez, J., Souque, P., Blanc, C., Chardenoux, S., Lafosse, I., Hardy, D., Nemirov, K., Guinet, F., Langa Vives, F., Majlessi, L., Charneau, P.
10.1101/2021.02.03.429211 — Posted: 2021-02-03
Identification of the SHREK family of proteins as broad-spectrum host antiviral factors
Dabbagh, D., He, S., Hetrick, B., Chilin, L., Andalibi, A., Wu, Y.
10.1101/2021.02.02.429469 — Posted: 2021-02-03
Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection
Yadav, P., Kumar, S., Agarwal, K., Jain, M., Patil, D., Maithal, K., Mathapati, B., Giri, S., Mohandas, S., Shete, A., Sapkal, G., Patil, D., Dey, A., Chandra, H., Deshpande, G., Gupta, N., Nyayanit, D., Kaushal, H., Sahay, R., Tripathy, A., Jain, R., Kumar, A., Sarkale, P., Baradkar, S., Rajanathan, C., Raju, H. P., Patel, S., Shah, N., Dwivedi, P., Singh, D., Abraham, P.
10.1101/2021.02.02.429480 — Posted: 2021-02-03
In silico, in vitro and in cellulo models for monitoring SARS-CoV-2 spike/human ACE2 complex, viral entry and cell fusion
Lapaillerie, D., Chariler, C., Fernandes, H. S., Sousa, S., Lesbats, P., Weigel, P., Favereaux, A., Guyonnnet-Duperat, V., Parissi, V.
10.1101/2021.02.03.429555 — Posted: 2021-02-03
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection
Pekayvaz, K., Leunig, A., Kaiser, R., Brambs, S., Joppich, M., Janjic, A., Popp, O., Polewka, V., Wange, L. E., Gold, C., Kirchner, M., Muenchhoff, M., Hellmuth, J. C., Scherer, C., Eser, T., Deak, F., Kuhl, N., Linder, A., Saar, K., Tomas, L., Schulz, C., Enard, W., Kroidl, I., Geldmacher, C., von Bergwelt-Baildon, M., Keppler, O. T., Zimmer, R., Mertins, P., Huebner, N., Hoelscher, M., Massberg, S., Stark, K., Nicolai, L.
10.1101/2021.02.03.429351 — Posted: 2021-02-03
Potent in vitro Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
Ma, H., Zeng, W., Meng, X., Huang, X., Yang, Y., Zhao, D., Zhou, P., Wang, X., Zhao, C., Sun, Y., Wang, P., Ou, H., Hu, X., Xiang, Y., Jin, T.
10.1101/2021.02.02.429311 — Posted: 2021-02-03
CovRadar: Continuously tracking and filtering SARS-CoV-2 mutations for molecular surveillance
Wittig, A., Miranda, F., Tang, M., Hölzer, M., Renard, B. Y., Fuchs, S.
10.1101/2021.02.03.429146 — Posted: 2021-02-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).